We are delighted to invite you to this symposium which will be held on 27th of April 2023 from 2pm to 6pm in the Kennedy Lecture Theatre at UCL’s Institute of Child Health, WC1N 1EH.

The results of recent clinical trials suggest that we are on the cusp of a new era in Alzheimer’s disease therapeutics and may soon have drugs that can both impact on the fundamental biology of the disease, and slow functional decline for patients.

However, this comes with considerable costs and logistical challenges for delivery and safety monitoring within the NHS; and will have implications for research and future clinical trials.

This symposium brings together clinicians, industry representatives, regulators, patients, and charities to consider the opportunities and the challenges ahead, through a series of talks, interactive round table discussions, and audience participation, led by a faculty of international experts from UCL and the USA.

Places are limited and tickets include a networking drinks reception after the event.

Instead of a registration fee, we ask that attendees consider donating to Rare Dementia Support, funded by the National Brain Appeal, in our fundraising to build the world’s first Rare Dementia Support Centre. Read more here

For those unable to join in person, please see the link below to join on the day. The event will also be recorded.

https://www.youtube.com/live/0KoGaPzhnas?feature=share

Preparing for Disease Modifying Therapies for Dementia